tiletamine hydrochloride has been researched along with cyclosporine in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Eddington, ND; Salama, NN; Scott, KR | 1 |
| Dunsmore, CJ; Kontopidis, G; Malone, K; Moir, E; Page, AP; Taylor, P; Turner, NJ; Walkinshaw, MD; Wear, MA; Yang, Y | 1 |
| Asanuma, H; Kanno, Y; Kono, H; Mizuno, R; Morita, S; Nakagawa, K; Oya, M; Shimoda, M; Shinoda, K; Umezawa, K; Yoshida, T | 1 |
3 other study(ies) available for tiletamine hydrochloride and cyclosporine
| Article | Year |
|---|---|
The influence of enaminones on the transport and oral bioavailability of P-glycoprotein substrate therapeutic agents.
Topics: Administration, Oral; Aniline Compounds; Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Availability; Biological Transport; Brain; Caco-2 Cells; Carbon Radioisotopes; Cyclohexanones; Cyclosporine; Humans; Male; Paclitaxel; Rats; Rats, Sprague-Dawley; Substrate Specificity; Tissue Distribution | 2004 |
Structure-based discovery of a family of synthetic cyclophilin inhibitors showing a cyclosporin-A phenotype in Caenorhabditis elegans.
Topics: Animals; Caenorhabditis elegans; Crystallography, X-Ray; Cyclohexanones; Cyclophilin A; Cyclosporine; Enzyme Inhibitors; Humans; Hydrophobic and Hydrophilic Interactions; Models, Molecular; Molecular Structure; Phenotype; Protein Binding; Structure-Activity Relationship | 2007 |
Dehydroxymethylepoxyquinomicin, a novel nuclear factor-κB inhibitor, prevents the development of cyclosporine A nephrotoxicity in a rat model.
Topics: Animals; Benzamides; Cyclohexanones; Cyclosporine; DNA; Immunosuppressive Agents; Kidney; Kidney Diseases; Male; NF-kappa B; Protective Agents; Rats, Sprague-Dawley | 2020 |